Research output per year
Research output per year
Fingerprint
Dive into the research topics where Oncology, Nebraska Medicine is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Zaid S Al-Kadhimi, MD
- Oncology/Hematology - Associate Professor
- Pathology & Microbiology - Courtesy Associate Professor
- Oncology, Nebraska Medicine - Staff Physician
Person: Academic
-
James Olen Armitage, MD
- Oncology/Hematology - Joe Shapiro Chair of Oncology, UNMC Distinguished Cancer Research Professorship, Professor
- Eppley Institute for Cancer Research - Courtesy Professor
- James O Armitage Center for Hematological Malignancies Research - Executive Committee Member
- Fred & Pamela Buffett Cancer Center - Member
- Oncology, Nebraska Medicine - Staff Physician
Person: Member, Academic, Clinician
-
Raymond C Bergan, MD
- Eppley Institute for Cancer Research - Professor & Research Scientist
- Fred & Pamela Buffett Cancer Center - Deputy Director, Member
- Oncology/Hematology - Professor
- Oncology, Nebraska Medicine - Staff Physician-Specialty
Person: Academic, Administrator, Clinician
-
ABCL-455 Multicenter Retrospective Analysis of Single-Route Prophylaxis in Aggressive B-Cell Lymphomas
Orellana-Noia, V., Reed, D., McCook, A., Sen, J., Barlow, C., Malecek, M. K., Watkins, M., Kahl, B., Spinner, M., Advani, R., Voorhees, T., Snow, A., Grover, N., Ayers, A., Romancik, J., Liu, Y., Huntington, S., Chavez, J., Saeed, H., Lazaryan, A., & 33 others, Oct 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S381Research output: Contribution to journal › Article › peer-review
-
A Better Treatment for Advanced-Stage Hodgkin's Lymphoma?
Longo, D. L. & Armitage, J. O., Jul 28 2022, In: New England Journal of Medicine. 387, 4, p. 370-372 3 p.Research output: Contribution to journal › Review article › peer-review
-
Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer
NBRST Investigators Group, 2022, (Accepted/In press) In: Annals of Surgical Oncology.Research output: Contribution to journal › Article › peer-review
Open Access